Owen Hughes
CIK 1575933 · Chief Executive Officer · last filed 2026-07-14
Owen Hughes is a Chief Executive Officer who has filed 43 SEC Form 4 insider transactions across 9 companies since 2014. The most recent filing, for XOMA, was dated Jul 14, 2026. Across all open-market trades the lifetime net is +$111.3K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $13.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$13.63M
9
43
$111.3K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XOMA | Chief Executive Officer | 0 | $40.17 | $0 | $0 | 1 | 2026-07-14 |
| CCCC | Director | — | $3.55 | — | $0 | 4 | 2026-06-26 |
| ANAB | Director | — | $52.11 | — | $0 | 1 | 2026-05-13 |
| XOMAP | Chief Executive Officer | 191,559 | $24.98 | $4.79M | $1.30M | 11 | 2026-04-22 |
| ImageneBio, Inc. (IKNA) Delisted | Director | — | $17.16 | — | $0 | 3 | 2024-06-10 |
| Radius Health, Inc. (RDUS) Delisted | Director | 0 | $30.00 | $0 | -$102.7K | 15 | 2022-08-15 |
| PARDES BIOSCIENCES, INC. (PRDS) Delisted | Director | 30,000 | $2.16 | $64.8K | $0 | 2 | 2021-12-30 |
| Translate Bio, Inc. (TBIO) Delisted | Director | 0 | $0.00 | $0 | -$1.13M | 4 | 2021-09-14 |
| CGEM | President and CEO | 506,226 | $17.47 | $8.84M | $52.5K | 2 | 2021-01-14 |
Recent Filings
43 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-14 | XOMA | Mixed | −294,016 | $0 | EDGAR |
| 2026-06-26 | CCCC | Grant (A) | — | $0 | EDGAR |
| 2026-05-13 | ANAB | Grant (A) | — | $0 | EDGAR |
| 2026-04-22 | XOMAP | Exer (M) | +10,568 | $0 | EDGAR |
| 2026-03-17 | XOMAP | Grant (A) | +82,428 | $0 | EDGAR |
| 2025-12-08 | XOMAP | Buy (P) | +100,000 | $2.50M | EDGAR |
| 2025-09-23 | XOMAP | Exer (M) | +35,567 | $0 | EDGAR |
| 2025-06-20 | CCCC | Grant (A) | — | $0 | EDGAR |
| 2025-05-21 | XOMAP | Mixed | +27,722 | -$650.7K | EDGAR |
| 2024-11-13 | XOMAP | Mixed | +31,479 | -$655.3K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.